Oncogene - Table of Contents alert Volume 32 Issue 27

TABLE OF CONTENTS Volume 32, Issue 27 (July 2013) In this issue Review Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Naturejobs presents the: Naturejobs Career Expo September 19, 2013 The Business Design Centre, London, UK  Click here for more information or to register for this conference today! Review Top Rejuvenating Bi(d)ology S S Zinkel, X M Yin and A Gross Oncogene 2013 32: 3213-3219; advance online publication, October 15, 2012; 10.1038/onc.2012.454 Abstract | Full Text Original Articles Top Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression A Ben-Shmuel, A Shvab, N Gavert, T Brabletz and A Ben-Ze'ev Oncogene 2013 32: 3220-3230; advance online publication, August 6, 2012; 10.1038/onc.2012.340 Abstract | Full Text Bach1 is critical for the transformation of mouse embryonic fibroblasts by RasV12 and maintains ERK signaling A Nakanome, A Brydun, M Matsumoto, K Ota, R Funayama, K Nakayama, M Ono, K Shiga, T Kobayashi and K Igarashi Oncogene 2013 32: 3231-3245; advance online publication, July 30, 2012; 10.1038/onc.2012.336 Abstract | Full Text Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility O Aprelikova, J Palla, B Hibler, X Yu, Y E Greer, M Yi, R Stephens, G L Maxwell, A Jazaeri, J I Risinger, J S Rubin and J Niederhuber Oncogene 2013 32: 3246-3253; advance online publication, August 13, 2012; 10.1038/onc.2012.351 Abstract | Full Text The mTOR inhibitor rapamycin opposes carcinogenic changes to epidermal Akt1/PKBα isoform signaling K Sully, O Akinduro, M P Philpott, A S Naeem, C A Harwood, V E Reeve, R F O'Shaughnessy and C Byrne Oncogene 2013 32: 3254-3262; advance online publication, August 13, 2012; 10.1038/onc.2012.338 Abstract | Full Text RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex B A Abhari, S Cristofanon, R Kappler, D von Schweinitz, R Humphreys and S Fulda Oncogene 2013 32: 3263-3273; advance online publication, August 13, 2012; 10.1038/onc.2012.337 Abstract | Full Text Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer M Razandi, A Pedram, V C Jordan, S Fuqua and E R Levin Oncogene 2013 32: 3274-3285; advance online publication, August 20, 2012; 10.1038/onc.2012.335 Abstract | Full Text Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis Open P Dong, M Karaayvaz, N Jia, M Kaneuchi, J Hamada, H Watari, S Sudo, J Ju and N Sakuragi Oncogene 2013 32: 3286-3295; advance online publication, July 30, 2012; 10.1038/onc.2012.334 Abstract | Full Text HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma X Qiu, S Dong, F Qiao, S Lu, Y Song, Y Lao, Y Li, T Zeng, J Hu, L Zhang, L Zhang and H Fan Oncogene 2013 32: 3296-3305; advance online publication, April 22, 2013; 10.1038/onc.2013.150 Abstract | Full Text Short Communication Top miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling C A Gebeshuber and J Martinez Oncogene 2013 32: 3306-3310; advance online publication, August 27, 2012; 10.1038/onc.2012.372 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.